Peptides Studied in
Fat Loss Research
Retatrutide, MOTS-c, and Tesamorelin represent the most-studied compounds in metabolic modulation, fat oxidation, and body composition research. Research-grade, 99%+ purity, Aegis COA on every order.
What the Research Covers
Metabolic and fat loss peptide research encompasses investigations into how synthetic and naturally derived compounds influence energy homeostasis, adipose tissue biology, and body composition. The most active areas include GLP-1 and multi-receptor agonist pharmacology, mitochondrial energy regulation, and GH axis modulation. Retatrutide, MOTS-c, and Tesamorelin represent three mechanistically distinct approaches that have each accumulated peer-reviewed research literature in preclinical and clinical settings.
The research compounds on this page are intended exclusively for laboratory research use and are not approved for therapeutic or dietary applications. All findings referenced reflect published preclinical and clinical trial data. Researchers seeking reproducible results should source compounds with batch-specific COA documentation confirming purity and molecular identity.
Fat Loss and Metabolic Research Compounds
Retatrutide
Retatrutide (GLP-1/GIP/Glucagon Triple Agonist)
$199.99 / 5mg
Retatrutide is a synthetic peptide that simultaneously agonizes GLP-1, GIP, and glucagon receptors, a triple-mechanism profile that distinguishes it from other metabolic research compounds. A Phase 2 trial published in the New England Journal of Medicine demonstrated substantial body weight reduction at 48 weeks. Research is ongoing into its effects on energy expenditure, hepatic fat, glucose homeostasis, and cardiovascular markers.
MOTS-c
MOTS-c (Mitochondrial Open Reading Frame Peptide)
$99.99 / 5mg
MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial genome. Research has examined its role as a metabolic regulator acting through the AMPK pathway in skeletal muscle, promoting glucose uptake and fatty acid oxidation. Animal model studies have shown reductions in high-fat-diet-induced weight gain and improved insulin sensitivity. Its mitochondrial origin makes it a unique tool for studying energy metabolism and metabolic disease.
Tesamorelin
Tesamorelin (Synthetic GHRH Analogue)
$99.99 / 10mg
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) with an FDA-approved clinical application for HIV-associated lipodystrophy. This regulatory history gives it one of the most documented safety and efficacy profiles of any research peptide. Studies have examined its effects on visceral adipose tissue reduction, IGF-1 elevation, and body composition in multiple research populations.
Explore the Research
Metabolic Research Peptides: Common Questions
What peptides are most studied for fat loss and metabolic research?
The three primary compounds in this research category are Retatrutide, MOTS-c, and Tesamorelin. Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors that has generated significant research interest following Phase 2 trial results. MOTS-c is a mitochondria-derived peptide studied for AMPK pathway activation and fat oxidation. Tesamorelin is an FDA-approved GHRH analogue studied for visceral fat reduction. All three are available as research-grade compounds from Blackwell BioLabs.
How does Retatrutide work in metabolic research models?
Retatrutide acts as a simultaneous agonist of three hormone receptors: GLP-1, GIP, and glucagon. This triple receptor activity underlies its documented metabolic effects in clinical research. A Phase 2 trial demonstrated significant body weight reduction at 48 weeks. Researchers are investigating its effects on energy expenditure, satiety signaling, glucose homeostasis, and hepatic fat metabolism.
What is MOTS-c and why is it studied in fat loss research?
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome. Research has examined its role as a regulator of metabolic homeostasis, its ability to activate the AMPK pathway in skeletal muscle, increase glucose uptake, and promote fatty acid oxidation. Animal model studies have demonstrated reductions in high-fat-diet-induced obesity and improvements in insulin sensitivity.
How does Tesamorelin differ from Retatrutide and MOTS-c in mechanism?
Tesamorelin operates through the GH axis: as a GHRH analogue, it stimulates GH secretion from the pituitary, which in turn increases lipolysis in visceral adipose tissue. Retatrutide acts directly on peripheral metabolic receptors. MOTS-c modulates mitochondrial energy metabolism. All three represent mechanistically distinct approaches to metabolic research.
Is Retatrutide available for laboratory research?
Yes. Retatrutide is available as a research-grade lyophilized peptide for laboratory research purposes only. It is not approved for human use outside of regulated clinical trial settings. Blackwell BioLabs supplies it for in vitro and preclinical research with a batch-specific COA from Aegis Analytical confirming 99%+ purity.
What purity standard applies to metabolic research peptides?
All Blackwell BioLabs metabolic compounds are verified at 99%+ purity with batch-specific Certificates of Analysis from Aegis Analytical, an independent third-party laboratory. Mass spectrometry confirms molecular identity on every batch.
Do these compounds require special storage conditions?
Yes. All three are supplied as lyophilized powders. In lyophilized form, they should be stored protected from heat, light, and moisture. Once reconstituted, refrigerated storage is required and compounds should be used within a defined window. Batch-specific COA documentation is included with every order.
Ready to Source Research-Grade Metabolic Compounds?
All products intended exclusively for laboratory research. Not for human consumption. Aegis COA included with every order.
All products on this site are intended exclusively for laboratory research and analytical use. They are not intended for human or veterinary use, and are not approved by any regulatory agency for diagnostic, therapeutic, or preventive purposes. Not for human consumption.